Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Zosano Pharma Corp | d617111d10q.htm |
| EX-31.1 - EX-31.1 - Zosano Pharma Corp | d617111dex311.htm |
| EX-10.4 - EX-10.4 - Zosano Pharma Corp | d617111dex104.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, John Walker, the Chief Executive Officer of Zosano Pharma Corporation (the “Company”), hereby certify that:
1. The Quarterly Report on Form 10-Q for the period ended June 30, 2018 of the Company (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 9, 2018 | By: | /s/ John Walker | ||||
| John Walker | ||||||
| Chief Executive Officer | ||||||
| (Principal Executive Officer and Principal Financial Officer) |